1. Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy by Fabian Zohren, Ingmar Bruns, Sabrina Pechtel, Thomas Schroeder, Roland Fenk, Akos Czibere, Georg Maschmeyer, Dorothea Kofahl-Krause, Norbert Niederle, Gerhard Heil, Christoph Losem, Manfred Welslau, Wolfram Brugger, Ulrich Germing, Ralf Kronenwett, Juergen Barth, Mathias J. Rummel, Rainer Haas, and Guido Kobbe Blood Volume 126(12):1407-1414 September 17, 2015 ©2015 by American Society of Hematology

2. Consolidated Standards of Reporting Trials diagram. Fabian Zohren et al. Blood 2015;126:1407-1414 ©2015 by American Society of Hematology

3. Pretreatment Bcl-2/IgH status and level. Fabian Zohren et al. Blood 2015;126:1407-1414 ©2015 by American Society of Hematology

4. Posttreatment Bcl-2/IgH status and level. Fabian Zohren et al. Blood 2015;126:1407-1414 ©2015 by American Society of Hematology

5. Follow-up Bcl-2/IgH status and level. Fabian Zohren et al. Blood 2015;126:1407-1414 ©2015 by American Society of Hematology